Concurrent pharmacokinetic analysis of plasma cocaine and adrenocorticotropic hormone in men

被引:29
作者
Sholar, MB [1 ]
Mendelson, JH [1 ]
Mello, NK [1 ]
Siegel, AJ [1 ]
Kaufman, MJ [1 ]
Levin, JM [1 ]
Renshaw, PF [1 ]
Cohen, BM [1 ]
机构
[1] Harvard Univ, McLean Hosp, Sch Med, Alcohol & Drug Abuse Res Ctr, Belmont, MA 02178 USA
关键词
D O I
10.1210/jc.83.3.966
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to determine the covariance between plasma cocaine and ACTH pharmacokinetics. Twelve healthy male occasional cocaine users participated in a double blind study. Intravenous cocaine (0.2 mg/kg) or placebo was infused over 1 min, and samples for cocaine, ACTH and cortisol analysis were collected at 2, 4, 8, 12, 16, 20, 30, 40, 60, 80, 120, 180, and 240 min. Peak cocaine plasma levels averaged 101.2 +/- 14.6 ng/mL. ACTH increases were significantly correlated (P < 0.0001) with increases in plasma cocaine levels (r = 0.67; r(2) = 0.44). Pharmacokinetic analysis showed that the t(max) (observed time to maximum concentration) values for cocaine (6.0 +/- 1.4 min) and ACTH (7.3 +/- 1.2 min) were almost identical. The area under the curve was calculated using the trapezoidal rule. The area under the curve for plasma cocaine was 6463 +/- 1070 ng/min.mL, and the area under the curve for ACTH was 1873 +/- 188 pmol/min.L. The mean half-life for plasma cocaine was 46.7 +/- 4.0 min, and that for ACTH was 35.8 +/- 5.1 min. Cardiovascular and subjective effect measures were correlated with concurrent increases in plasma cocaine and ACTH levels.
引用
收藏
页码:966 / 968
页数:3
相关论文
共 17 条
[1]   SOLID-PHASE EXTRACTION AND GC/MS QUANTITATION OF COCAINE, ECGONINE METHYL-ESTER, BENZOYLECGONINE, AND COCAETHYLENE FROM MECONIUM, WHOLE-BLOOD, AND PLASMA [J].
ABUSADA, GM ;
ABUKHALAF, IK ;
ALFORD, DD ;
VINZONBAUTISTA, I ;
PRAMANIK, AK ;
ANSARI, NA ;
MANNO, JE ;
MANNO, BR .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1993, 17 (06) :353-358
[2]  
BOROWSKY B, 1991, J PHARMACOL EXP THER, V256, P204
[3]   COCAINE STIMULATES RAT HYPOTHALAMIC CORTICOTROPIN-RELEASING HORMONE-SECRETION INVITRO [J].
CALOGERO, AE ;
GALLUCCI, WT ;
KLING, MA ;
CHROUSOS, GP ;
GOLD, PW .
BRAIN RESEARCH, 1989, 505 (01) :7-11
[4]   KINETICS OF COCAINE DISTRIBUTION, ELIMINATION, AND CHRONOTROPIC EFFECTS [J].
CHOW, MJ ;
AMBRE, JJ ;
RUO, TI ;
ATKINSON, AJ ;
BOWSHER, DJ ;
FISCHMAN, MW .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (03) :318-324
[5]  
LEVY AD, 1991, J PHARMACOL EXP THER, V259, P495
[6]  
MENDELSON JH, 1992, J PHARMACOL EXP THER, V263, P505
[7]   Drug therapy: Management of cocaine abuse and dependence [J].
Mendelson, JH ;
Mello, NK .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (15) :965-972
[8]  
MENDELSON JH, 1992, NEUROPSYCHOPHARMACOL, V17, P157
[9]   COCAINE INDUCED SECRETION OF ACTH, BETA-ENDORPHIN, AND CORTICOSTERONE [J].
MOLDOW, RL ;
FISCHMAN, AJ .
PEPTIDES, 1987, 8 (05) :819-822
[10]   COCAINE INHIBITION OF LIGAND-BINDING AT DOPAMINE, NOREPINEPHRINE AND SEROTONIN TRANSPORTERS - A STRUCTURE-ACTIVITY STUDY [J].
RITZ, MC ;
CONE, EJ ;
KUHAR, MJ .
LIFE SCIENCES, 1990, 46 (09) :635-645